Effect of sex on the efficacy of patients receiving immune checkpoint inhibitors in advanced non‐small cell lung cancer

Effect of sex on the efficacy of patients receiving immune checkpoint inhibitors in advanced non‐small cell lung cancer

Abstract Immune checkpoint inhibitors (ICIs) have shown promising efficacy in the treatment of non‐small cell lung cancer (NSCLC). Sex‐associated dimorphism in immune system response is acknowledged, but the effect of patients’ sex on efficacy of ICIs as treatment in NSCLC still remains controversia...

Full description

Bibliographic Details
Main Authors: Chengdi Wang, Wenliang Qiao, Yuting Jiang, Min Zhu, Jun Shao, Pengwei Ren, Dan Liu, Weimin Li
Format: Article
Language:English
Published: Wiley 2019-07-01
Series:Cancer Medicine
Subjects:
chemotherapy
CTLA‐4
immune checkpoint inhibitors
NSCLC
PD‐1
PD‐L1
Online Access:https://doi.org/10.1002/cam4.2280

Internet

https://doi.org/10.1002/cam4.2280

Similar Items